You have searched for "US drug company"
Showing 51-60 of 222
If 2015 was a dream year for Wall Street’s top dealmakers, 2016 is starting to take a nightmarish turn. The move by the Obama administration to suddenly change the rules has sent a chilling message to dealmakers and comes on top of a number of legal challenges to big transactions. The political uncertainty and antitrust concerns mean that firms will think twice about future tie-ups that consolidate industries and move tax dollars offshore.
NEW YORK: The U.S. Department of Justice on Monday sued ValueAct Capital for violating notification requirements related to Halliburton Co's deal to buy rival Baker Hughes Inc, in a case that the activist hedge fund says it will fight
There seems to be a pill for every ill – and then some.
BOSTON: Hedge funds on Tuesday lost an estimated $5.3 billion on drugmaker Valeant Pharmaceuticals' stock meltdown, with billionaire investors William Ackman and Jeffrey Ubben taking the brunt of the hit - losing more than $700 million each, according to data from research firm Symmetric.IO.
NEW DELHI (Reuters) - Indian opposition leaders raised concerns on Tuesday with Prime Minister Narendra Modi over widening protests on university campuses, as the heated political atmosphere again threatened to stall reforms in parliament.
LONDON (Reuters) - The world is once again asking scientists and drugmakers to come up rapidly with a vaccine for a viral disease that, in the latest case, few people had heard of until a few weeks ago, and even fewer feared.